BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2180571)

  • 1. c-Ha-ras-I oncogene-induced differentiation and natural killer cell resistance in a human colorectal carcinoma cell line.
    Bagli DJ; D'Emilia JC; Summerhayes IC; Steele GD; Barlozzari T
    Cancer Res; 1990 Apr; 50(8):2518-23. PubMed ID: 2180571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells.
    Lanza LA; Wilson DJ; Ikejiri B; Roth JA; Grimm EA
    J Immunol; 1986 Oct; 137(8):2716-20. PubMed ID: 3489774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
    Johnson PW; Trimble WS; Hozumi N; Roder JC
    J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Ha-ras oncogene transfection does not affect NK cell sensitivity of human colorectal carcinoma cell lines.
    van Ierssel GJ; de Vries JE; Mierement-Ooms MA; van der Zon AM; ten Kate J; Lamers CB; Verspaget HW
    Anticancer Res; 1995; 15(2):349-52. PubMed ID: 7763005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukemia-derived cell lines and clones as models for mechanistic analysis of natural killer cell-mediated cytotoxicity.
    Zarcone D; Tilden AB; Friedman HM; Grossi CE
    Cancer Res; 1987 May; 47(10):2674-82. PubMed ID: 2436754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells.
    Versteeg R; Peltenburg LT; Plomp AC; Schrier PI
    J Immunol; 1989 Dec; 143(12):4331-7. PubMed ID: 2512356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
    Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
    J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.
    Kaufman DS; Schoon RA; Leibson PJ
    J Immunol; 1993 Feb; 150(4):1429-36. PubMed ID: 8432986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S
    Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of melanoma cell lines to natural killer cells: a role for oncogene-modulated HLA class I expression?
    Schrier PI; Versteeg R; Peltenburg LT; Plomp AC; van 't Veer LJ; Krüse-Wolters KM
    Semin Cancer Biol; 1991 Feb; 2(1):73-83. PubMed ID: 1912519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis.
    Sheil JM; Gallimore PH; Zimmer SG; Sopori ML
    J Immunol; 1984 Mar; 132(3):1578-82. PubMed ID: 6319497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells.
    Seebach JD; Comrack C; Germana S; LeGuern C; Sachs DH; DerSimonian H
    J Immunol; 1997 Oct; 159(7):3655-61. PubMed ID: 9317166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
    Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
    J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B.
    Kim HR; Park HJ; Park JH; Kim SJ; Kim K; Kim J
    Cancer Immunol Immunother; 2004 May; 53(5):461-70. PubMed ID: 14648068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered IFNgamma signaling and preserved susceptibility to activated natural killer cell-mediated lysis of BCR/ABL targets.
    Cebo C; Voutsadakis IA; Da Rocha S; Bourhis JH; Jalil A; Azzarone B; Turhan AG; Chelbi-Alix M; Chouaib S; Caignard A
    Cancer Res; 2005 Apr; 65(7):2914-20. PubMed ID: 15805294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells.
    Fresa KL; Karjalainen HE; Tevethia SS
    J Immunol; 1987 Feb; 138(4):1215-20. PubMed ID: 3027174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible cellular transformation by a metallothionein-ras hybrid oncogene leads to natural killer cell susceptibility.
    Trimble WS; Johnson PW; Hozumi N; Roder JC
    Nature; 1986 Jun 19-25; 321(6072):782-4. PubMed ID: 3520342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.